[ACRX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
16-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -9.99%
YoY- -49.12%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 442 2 1,862 443 511 738 1,368 -52.94%
PBT -8,674 -7,917 -8,375 -9,846 -8,956 -8,918 -8,930 -1.92%
Tax -321 467 796 5 858 698 931 -
NP -8,353 -7,917 -8,375 -9,851 -8,956 -8,918 -8,930 -4.35%
Tax Rate - - - - - - - -
Total Cost 8,795 7,919 10,237 10,294 9,467 9,656 10,298 -9.99%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -1,889.82 -395,850.00 -449.79 -2,223.70 -1,752.64 -1,208.40 -652.78 103.25%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -1.15 -1.24 -1.40 -1.65 -1.58 -1.93 -2.03 -31.55%
EPS Diluted -1.15 -1.24 -1.40 -1.65 -1.58 -1.93 -2.03 -31.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.